<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Diagn Pathol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Diagn Pathol</journal-id>
      <journal-title-group>
        <journal-title>Diagnostic Pathology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1746-1596</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23186166</article-id>
      <article-id pub-id-type="pmc">3584922</article-id>
      <article-id pub-id-type="publisher-id">1746-1596-7-163</article-id>
      <article-id pub-id-type="doi">10.1186/1746-1596-7-163</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes" id="A1">
          <name>
            <surname>Song</surname>
            <given-names>Wu</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>songwu@mail.sysu.edu.cn</email>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes" id="A2">
          <name>
            <surname>Chen</surname>
            <given-names>Wenfang</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>chwfang@mail.sysu.edu.cn</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Zhang</surname>
            <given-names>Sheng</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>shengzhangzsyy@sina.cn</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Peng</surname>
            <given-names>Jianjun</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>jianjunpenggz@sina.com</email>
        </contrib>
        <contrib contrib-type="author" corresp="yes" id="A5">
          <name>
            <surname>He</surname>
            <given-names>Yulong</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>ylh@medmail.com.cn</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Surgery, the First Affiliated Hospital, Sun Yat-sen University, 58# Zhongshan Road 2, Guangzhou 510080, China</aff>
      <aff id="I2"><label>2</label>Department of Pathology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou China</aff>
      <pub-date pub-type="collection">
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>27</day>
        <month>11</month>
        <year>2012</year>
      </pub-date>
      <volume>7</volume>
      <fpage>163</fpage>
      <lpage>163</lpage>
      <history>
        <date date-type="received">
          <day>31</day>
          <month>7</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>6</day>
          <month>11</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9;2012 Song et al; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <copyright-holder>Song et al; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.diagnosticpathology.org/content/7/1/163"/>
      <abstract>
        <p>Mixed adenoneuroendocrine carcinoma (MANEC) carcinomas rarely occur in the gallbladder. Here we reported a case of giant gallbladder unresectable mass with local liver invasion and omentum metastasis, which proved to be neuroendocrine carcinoma (NEC) by biopsy, received successful radical operation after neo-adjuvant chemotherapy plus somatostatin treatment. The patient showed good response as the neoplasm diminished dramatically and showed clear margin after 6 courses of treatment. A radical operation including cholecystectomy, hepatic wedge resection of the gallbladder fossa segment and lymph node of group 8a and 8p resection was performed successfully. Postoperative histopathological examination revealed neuroendocrine carcinoma mixed with adenocarcinoma in the gallbladder wall. Followed up showed no evidence of recurrence after 7&#x2009;months of the operation. We suggest that neo-adjuvant chemotherapy may be beneficial to gallbladder mixed neuroendocrine carcinomas in an advanced stage which could also be advantageous to NEC of other organs.</p>
        <sec>
          <title>Virtual slides</title>
          <p>
            <ext-link ext-link-type="uri" xlink:href="http://www.diagnosticpathology.diagnomx.eu/vs/2731892837743787">http://www.diagnosticpathology.diagnomx.eu/vs/2731892837743787</ext-link>
          </p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Gallbladder</kwd>
        <kwd>Neuroendocrine tumors</kwd>
        <kwd>Neo-adjuvant chemotherapy</kwd>
        <kwd>Mixed adenoneuroendocrine carcinoma</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>Neuroendocrine tumors are uncommon diseases which mostly occur in the gastrointestinal tract, pancreas and lung. Epidemiology data from several medical centers in western countries indicate the incidence of NETs is about 2.5-5 /100,000 people. NETs occur in the gallbladder are rather rare and only account for 0.5% of all NETs [<xref ref-type="bibr" rid="B1">1</xref>]. Recently, probably due to the progress of the diagnostic techniques and the rising awareness of this uncommon tumor, the incidence of the NETs has been increasing [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>] as well as the gallbladder NETs [<xref ref-type="bibr" rid="B4">4</xref>]. Additionally, Because of the aggressiveness of the tumor and lack of specific symptoms, patients are often diagnosed at an advanced stage when radical surgery is not available. Until now no consensus was reached in terms of the standard treatment, chemotherapy strategy and operational procedure for gallbladder NETs. Here, we report a rare case diagnosed as unresectable gallbladder neuroendocrine carcinoma (GB-NEC) by preoperative biopsy, who successfully obtained radical resection after 6 periods of neo-adjuvant chemotherapy and somatostatin treatment, finally was proved to be mixed adenoneuroendocrine carcinoma (MANEC).</p>
    </sec>
    <sec>
      <title>Case report</title>
      <sec>
        <title>Clinic data</title>
        <p>A 55-year-old woman complained of mild epigastric discomfort was found to have a large impalpable mass in the gallbladder area with ultrasound examination. She was then admitted to the first affiliated hospital of Sun Yat-sen University. She had history of chronic cholecystitis for five years and no operation or other chronic diseases were found. Physical examination was negative. A slight impairment of liver function was found with AST 57 unit/L and ALT 68 unit/L (normal range&lt;40) while albumin and bilirubin were within the normal range. Blood and urine analysis were normal. Her serum tumor markers CEA was 43 ug/L (normal range 0~5 ug/L), CA 125 465 U/ml (normal range 0~35 U/ml) and CA 19&#x2013;9 100 U/ml (normal range 0~35 U/ml), all of which showed a significant elevation. Blood hormone test showed her serum CgA increased to 220&#x2009;ng/ml (normal range17~34 U/L), while 5-HIAA, 5-HT and cortisol level were normal. Abdominal ultrasound examination revealed massive ascites together with a mass measuring 14&#x2009;cm&#xD7;8.4&#x2009;cm in the gallbladder bed area closely adhering to the pancreatic head and liver. CT scan suggested that the gallbladder neoplasm invaded the neighboring liver, pancreatic head, peritoneum and omentum (Figure&#x2009;<xref ref-type="fig" rid="F1">1</xref>A). Lymph nodes enlargements were found in hepatic hilar region and liver segment 5 metastasis was suspected. PET/CT scan also demonstrated the results, without any other distant hyper-metabolic foci.</p>
        <fig id="F1" position="float">
          <label>Figure 1</label>
          <caption>
            <p><bold>Radiological and pathological data of the case before chemotherapy. </bold><bold>A</bold>. CT scan showed a gallbladder mass invading liver, head of pancreas with metastasis of peritoneum and enlarged lymphnodes in hepatic hilar. <bold>B</bold>. Diffuse small round cells with scanty cytoplasm and round nucleus (HE&#xD7;200). <bold>C</bold>. Strong positive cytoplasmic expression of Syn (IHC&#xD7;400). <bold>D</bold>. Over 80&#x2009;% tumor cells show positive expression of Ki-67 (IHC&#xD7;200).</p>
          </caption>
          <graphic xlink:href="1746-1596-7-163-1"/>
        </fig>
      </sec>
      <sec>
        <title>Preoperational pathological findings</title>
        <p>Diagnostic biopsy was thereafter performed. Histopathologically, the neoplasm was composed of diffuse small cells with scanty cytoplasm. The nuclei were round or short spindle-shaped exhibiting finely granular nuclear chromatin and inconspicuous nucleoli with large amount of mitotic count (&gt;20/10HPF). Tumor cells tend to be located around the small vessels in some area forming pseudorosettes (Figure&#x2009;<xref ref-type="fig" rid="F1">1</xref>B). Immunohistochemistry staining revealed diffuse strong expression of CD56, CgA, NSE and Syn (Figure&#x2009;<xref ref-type="fig" rid="F1">1</xref>C). Ki-67 index was over 80% (Figure&#x2009;<xref ref-type="fig" rid="F1">1</xref>D). The panel of antibodies which reviewed diffuse strong expression were summarized in Table&#x2009;<xref ref-type="table" rid="T1">1</xref>. Epithelial marker CK was positive while other markers such as CK7, CK20, and EMA were negative. Other markers such as LCA, CD99, Vimentin and S-100 were all negative. Gene detection showed no gene disruption in EWSR1 gene locus. Therefore, small cell neuroendocrine carcinoma in the gallbladder was diagnosed.</p>
        <table-wrap position="float" id="T1">
          <label>Table 1</label>
          <caption>
            <p>The panel of immunohistochemical reagents which showed diffuse positive</p>
          </caption>
          <table frame="hsides" rules="groups" border="1">
            <colgroup>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
            </colgroup>
            <thead valign="top">
              <tr>
                <th align="left">
                  <bold>Antibody</bold>
                </th>
                <th align="left">
                  <bold>Clone</bold>
                </th>
                <th align="left">
                  <bold>Manufacturer</bold>
                </th>
                <th align="left">
                  <bold>Dilution</bold>
                </th>
              </tr>
            </thead>
            <tbody valign="top">
              <tr>
                <td align="left" valign="bottom">CK<hr/></td>
                <td align="left" valign="bottom">AE1/AE3<hr/></td>
                <td align="left" valign="bottom">Dako<hr/></td>
                <td align="left" valign="bottom">1/200<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">CD56<hr/></td>
                <td align="left" valign="bottom">CD564<hr/></td>
                <td align="left" valign="bottom">Novocastra<hr/></td>
                <td align="left" valign="bottom">Ready to use<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">CgA<hr/></td>
                <td align="left" valign="bottom">5H7<hr/></td>
                <td align="left" valign="bottom">Novocastra<hr/></td>
                <td align="left" valign="bottom">Ready to use<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">NSE<hr/></td>
                <td align="left" valign="bottom">E27<hr/></td>
                <td align="left" valign="bottom">ZSGB-BIO<hr/></td>
                <td align="left" valign="bottom">Ready to use<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Syn<hr/></td>
                <td align="left" valign="bottom">27&#x2009;G12<hr/></td>
                <td align="left" valign="bottom">Novocastra<hr/></td>
                <td align="left" valign="bottom">Ready to use<hr/></td>
              </tr>
              <tr>
                <td align="left">Ki-67</td>
                <td align="left">SP6</td>
                <td align="left">ZSGB-BIO</td>
                <td align="left">1/400</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec>
        <title>Treatment and following-up</title>
        <p>Considering the tumor is unresectable at this stage, neo-adjuvant chemotherapy and somatostatin treatments were adopted based on multi-disciplinary team (MDT) based discussion. The chemotherapy regiment is combination of Carboplatin 300&#x2009;mg/m<sup>2</sup>, VP16 100&#x2009;mg/m<sup>2</sup>, Paclitaxel 180&#x2009;mg/m<sup>2</sup> combined with Octreotide 30&#x2009;mg/month. The patient showed good response to the chemotherapy and the abdominal ascites was relieved after two courses of treatment. She presented mild anorexia and hair loss as the side effects of chemotherapy, which was alleviated after the supportive and nutritional therapy. After 4 courses of treatment, her serum tumor markers including CEA, CA125 and CA19-9 decreased to normal range. CT scan suggested the size of the mass reduced dramatically and the enlarged lymph node in hepatic hilar region can not be detected any more. Liver lesion in the fifth segment was found to be not metastasis but a hepatic cyst. PET/CT scan indicated a hyper-metabolic nodule in the gallbladder area, with no other lesion all around the body. After 6 courses of treatment, her serum tumor markers remain normal and CT scan found that the tumor was limited to the gallbladder area with clear margin to the pancreatic head (Figure&#x2009;<xref ref-type="fig" rid="F2">2</xref>A). Two enlarged lymph nodes were found in the hepatodudenal ligament. Considering the satisfying effect of the neo-adjuvant chemotherapy, we decided to perform radical operation on this patient based on MDT discussion.</p>
        <fig id="F2" position="float">
          <label>Figure 2</label>
          <caption>
            <p><bold>Radiological and pathological data of the case&#x2009;after chemotherapy. </bold><bold>A</bold>. The mass decreased and was limited to the gallbladder fossa with clear margin. <bold>B</bold>. Small round-shaped tumor cells in gallbladder wall with marked interstitial fibrosis (HE&#xD7;200). <bold>C</bold>. Positive expression of CgA in the cytoplasma of the tumor cells (IHC&#xD7;200). <bold>D</bold>. Scattered large and cribriform glands infiltrate the mucous and muscularis layers (HE&#xD7;200).</p>
          </caption>
          <graphic xlink:href="1746-1596-7-163-2"/>
        </fig>
        <p>Intra-operative findings showed a hard mass measuring 7&#x2009;cm&#xD7;3&#x2009;cm&#xD7;2&#x2009;cm in the gallbladder fossa, with clear margin to the pancreas. Palpable lymph nodes were found in the hepatodudenal ligament (group 12B). No metastasis was found in the liver and no para-aortic lymph node enlargement was detected. Cholecystectomy, hepatic wedge resection of the gallbladder fossa segment, lymph node dissection in hepatodudenal ligament and common hepatic artery (group 8a and 8p) were then performed. Postoperative pathological findings showed diffuse small round-shaped tumor cells in the gallbladder wall with marked interstitial fibrosis (Figure&#x2009;<xref ref-type="fig" rid="F2">2</xref>B). Compared with the biopsy, the tumor cells&#x2019; size, cell density and nuclear mitosis decreased. Immunohistochemistry staining revealed positive expression of CD56, CgA (Figure&#x2009;<xref ref-type="fig" rid="F2">2</xref>C), NSE, Syn and CK. The Ki-67 index is over 20%. In addition, scattered large, irregular and cribriform glandular composed of columnar neoplastic cells were found in the mucosa and muscularis layers of the gallbladder wall (Figure&#x2009;<xref ref-type="fig" rid="F2">2</xref>D). This moderately differentiated adenocarcinoma consisted about 40 percents of the whole tumor. Gallbladder serosa was not penetrated by the dysplasia glandular cells. There was no lymphovascular invasion in the sections and no metastasis was found in the dissected lymph nodes. The patient was diagnosed as MANEC (T3N0M0, stage III A).</p>
        <p>Postoperative adjuvant chemotherapy and somatostatin treatment were continued for 3 more courses. A regularly followed up showed tumor biomarkers remain in normal range and CT scan found no evidence of recurrence after 7&#x2009;months of the operation.</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>There are considerable discrepancies about the predilection sites of the NETs according to the database of various countries which may due to the different race [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. Though gastroenteropancreatic NETs are the most common type in the NETs representing 65-75% of all cases [<xref ref-type="bibr" rid="B6">6</xref>], they also occur in other organs such as ovary, testis and hepatobiliary system and so on. Gallbladder neuroendocrine tumors (GB-NETs) are extremely rare which only represent 2% in all gallbladder tumors [<xref ref-type="bibr" rid="B1">1</xref>].</p>
      <p>The average onset age of GB-NETs is 64&#x2009;years old with a female preponderance [<xref ref-type="bibr" rid="B7">7</xref>] , which is very similar with primary colorectal NEC that is reported to have a median age of 60&#x2009;years and a female to male ratio of 2:1 [<xref ref-type="bibr" rid="B8">8</xref>]. NETs are divided into functional and nonfunctional depending on whether the tumor cells can produce hormones and induce endocrine syndromes. Up to now 13 types of neuroendocrine cells have been found, which could release different types of bioactive molecules [<xref ref-type="bibr" rid="B6">6</xref>]. Most of the primary colorectal NEC patients have no carcinoid syndrome, so as the majority of the GB-NETs leading to it&#x2019;s easily to be omitted in the earlier stage [<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B10">10</xref>]. Patients often complain with nonspecific symptoms such as abdominal pain, epigastric discomfort and jaundice, with only 3.3%-3.7% in all cases presenting hormone-related syndromes [<xref ref-type="bibr" rid="B11">11</xref>]. As in our case, the patient complained about mild epigastric discomfort, without any hormone-related clinical manifestation.</p>
      <p>Gallbladder carcinomas are believed to originate from malignant transformation of epithelial atypical hyperplasia which often occurs during the chronic inflammation [<xref ref-type="bibr" rid="B12">12</xref>]. The origin of GB-NETs remains uncertain because neuroendocrine cells do not naturally exist in the mucosa of the gallbladder. One of the theories proposed that neuroendocrine cells could be generated from the stem cells deviating from their original differentiation during metaplastic process especially intestinal type [<xref ref-type="bibr" rid="B13">13</xref>]. As reported by Sakamoto [<xref ref-type="bibr" rid="B14">14</xref>], 10.7% of intestinal metaplasia was found in 103 cholecystolithiasis cases who had received cholecystectomy. Cholecystolithiasis and cholecystitis were also found in most cases of GB-NETs, which suggested GB-NETs might relate to chronic inflammation of the gallbladder [<xref ref-type="bibr" rid="B15">15</xref>] , while only two of ten cases of colorectal NEC have related inflammatory diseases such as ulcerative colitis and Crohn's disease. This difference may indicate that the origination and mechanism of GB-NETs is quite different from colorectal NEC [<xref ref-type="bibr" rid="B8">8</xref>]. As in our case, the patient also had history of chronic cholecystitis. Proliferation and aggregation of these cells in the metaplastic epithelium could be an early sign for the gallbladder neuroendocrine tumors. Very few cases of concurrent adenocarcinoma and neuroendocrine tumor in the gallbladder were reported [<xref ref-type="bibr" rid="B16">16</xref>-<xref ref-type="bibr" rid="B18">18</xref>]. In our case, both glandular and neuroendocrine differentiations were observed and no transitional region between the two parts was found, which suggested the tumor might arise independently from two different precursor cells in a synchronous fashion or arise from a multipotent stem cell. Another theory postulate heterotopic pancreas in the gallbladder may play a role in origin of GB-NETs. The enzyme secreted by the heterotopic pancreas would damage the gallbladder mucosa and lead to metaplasia, which was believed as a possible etiology for GB-NETs [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>].</p>
      <p>The diagnosis of GB-NETs is rarely made preoperatively because there is no specific symptoms and imageological change. Ultrasound, CT scan, MRI, PET-CT and somatostatin receptor scintigraphy (SRS) can provide useful information of NETs, but confirmed diagnosis can only be made by pathological examination. Endoscopic ultrasonography with fine needle aspiration can increase the diagnostic sensitivity from 74% to 90%, compare to the endoscopic ultrasonography only [<xref ref-type="bibr" rid="B21">21</xref>]. Definite diagnosis relies on diffuse and intensive expression of marker proteins such as chromogranin A (CgA), neuron-Specific Enolase (NSE) and synaptophysin (Syn). Because of the extremely rareness of the primary NETs of the gallbladder, metastasis from other organs such as lung should be excluded carefully [<xref ref-type="bibr" rid="B22">22</xref>]. Recent grading system suggested by WHO and ENETS depend mainly on Ki-67 index and mitotic count [<xref ref-type="bibr" rid="B23">23</xref>]. Mixed adenoneuroendocrine carcinoma is diagnosed only when both portions are more than 30% in the pathological examination. In our case, adenocarcinoma was not detected in the biopsy but in the surgical specimen. We believe that it&#x2019;s because of the specimen taken by the biopsy is limited so that the adenocarcinoma was omitted unintentionally. Another reason might be the curative effect of neo-adjuvant chemotherapy and somatostatin treatment, which killed majority of the tumor neuroendocrine cells and made the NEC portion less predominant.</p>
      <p>Personalized and comprehensive therapy is preferred in treatment of NETs. Surgery, radiotherapy, peptide receptor mediated radionuclide therapy, chemotherapy and biological target treatment are all optional in NETs. Different surgical procedures such as mere cholecystectomy and cholecystectomy plus liver segment resection and lymph node dissections were reported according to different cases [<xref ref-type="bibr" rid="B24">24</xref>]. It is estimated that 74% of the GB-NETs patients will suffer from recurrence and metastasis after mere cholecystectomy [<xref ref-type="bibr" rid="B25">25</xref>]. Laparoscopic cholecystectomy is not preferred because it may cause intraperitoneal dissemination of the GB-NETs [<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B27">27</xref>]. For early stage of GB-NETs such as T1N0, cholecystectomy is suggested. For advanced stage, cholecystectomy plus liver segment resection and lymph node dissection could increase the 5-year overall survival rate [<xref ref-type="bibr" rid="B21">21</xref>]. In some cases, chemotherapy was reported to increase the median survival time (4-31&#x2009;months) and relief the symptoms in GB-NETs [<xref ref-type="bibr" rid="B28">28</xref>]. The objective response rate (ORR) of EP regimen in GEP-NETs is 53-67%, while its median survival time is shorter than 16&#x2009;months [<xref ref-type="bibr" rid="B29">29</xref>]. Somatostatin analogues can inhibit the secretion of a broad range of hormones by binding to the somatostatin receptors on the NETs cell membrane. Recently, studies also found that somatostatin analogues can inhibit tumor cell growth directly by modulating the signal transduction of proliferation and apoptosis. Long-acting octreotide or lanreotide could prolong the overall survival rate of in metastatic mid-gut NET patient [<xref ref-type="bibr" rid="B30">30</xref>].</p>
      <p>The prognosis of GB-NETs is related to the tumor size, invasion depth, differentiation degree and metastasis state, with a 60.4% 5-year overall survival rate [<xref ref-type="bibr" rid="B15">15</xref>]. Poor differentiation and accompanied with adenocarcinoma predict a worse prognosis, while tumor limited to the gallbladder wall is a good prognostic indicator. For GB-NETs with local invasion and lymph node metastasis, patients who received extended lymph node dissection would still suffer from recurrence and metastasis and the median survival time is only 30.3&#x2009;months [<xref ref-type="bibr" rid="B25">25</xref>]. Extended operation including cholecystectomy, liver segment resection and lymph node dissection could increase the 5-year survival rate from 21.3% to 60.4% [<xref ref-type="bibr" rid="B31">31</xref>]. NCCN guideline indicated patients with the unresectable neuroendocrine tumor could receive palliative operation, adjuvant chemotherapy and somatostatin analogue treatment [<xref ref-type="bibr" rid="B32">32</xref>]. In our case, neo-adjuvant chemotherapy and somatostatin treatment successfully transformed the unresectable neoplasm and made radical operation available. Although at this stage it is hard to judge whether the radical operation could bring any long term advantage to patient of this kind, it does provide valuable experience in the management strategy of advanced gallbladder neuroendocrine tumors.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusion</title>
      <p>GB-NECs are rare malignancies with aggressive biological behavior. Most of the cases are non hormone-producing and often asymptomatic leading to missed diagnosis in early stages. Preoperational pathological diagnosis and identification of clinical stage are of vital importance. Neo-adjuvant chemotherapy and somatostatin treatment got satisfying effects in this unresectable case which could also be instructive in NEC of other places. We suggest that for those NETs of advanced stage, patients may benefit from preoperative pathological diagnosis and standard neo-adjuvant chemotherapy which may also make complete removal of the tumor by surgery possible.</p>
      <sec>
        <title>Consent</title>
        <p>A written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p>
      </sec>
    </sec>
    <sec>
      <title>Abbreviations</title>
      <p>MANEC: mixed adenoneuroendocrine carcinoma; NEC: neuroendocrine carcinoma; NET: neuroendocrine tumors; GB-NEC: gallbladder neuroendocrine carcinoma; EWSR1: Ewing sarcoma breakpoint region 1; SRS: somatostatin receptor scintigraphy; EP: VP16 and cis-platinum.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Author&#x2019; contributions</title>
      <p>WS and WFC contributed equally to this work. WS drafted the paper; WFC made analysis of the pathological examination and revised the paper carefully; SZ made contributions to acquisition of clinical data; JJP carried out the immunohistochemical staining; YLH designed and guided the research. All authors read and approved the final manuscript.</p>
    </sec>
  </body>
  <back>
    <sec>
      <title>Acknowledgements</title>
      <p>Supported by Science and Technology Planning Project of Guangdong Province, China (2011B031800240), National Natural Science Foundation of China (81101934).</p>
    </sec>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Yao</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Hassan</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Phan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Dagohoy</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Leary</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Mares</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Abdalla</surname>
            <given-names>EK</given-names>
          </name>
          <name>
            <surname>Fleming</surname>
            <given-names>JB</given-names>
          </name>
          <name>
            <surname>Vauthey</surname>
            <given-names>JN</given-names>
          </name>
          <name>
            <surname>Rashid</surname>
            <given-names>A</given-names>
          </name>
          <article-title>One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States</article-title>
          <source>J Clin Oncol</source>
          <year>2008</year>
          <volume>26</volume>
          <issue>18</issue>
          <fpage>3063</fpage>
          <lpage>3072</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2007.15.4377</pub-id>
          <pub-id pub-id-type="pmid">18565894</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Garcia-Carbonero</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Capdevila</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Crespo-Herrero</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Diaz-Perez</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Martinez</surname>
            <given-names>DPM</given-names>
          </name>
          <name>
            <surname>Alonso</surname>
            <given-names>OV</given-names>
          </name>
          <name>
            <surname>Sevilla-Garcia</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Villabona-Artero</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Beguiristain-Gomez</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Llanos-Munoz</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE)</article-title>
          <source>Ann Oncol</source>
          <year>2010</year>
          <volume>21</volume>
          <issue>9</issue>
          <fpage>1794</fpage>
          <lpage>1803</lpage>
          <pub-id pub-id-type="doi">10.1093/annonc/mdq022</pub-id>
          <pub-id pub-id-type="pmid">20139156</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hauso</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Gustafsson</surname>
            <given-names>BI</given-names>
          </name>
          <name>
            <surname>Kidd</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Waldum</surname>
            <given-names>HL</given-names>
          </name>
          <name>
            <surname>Drozdov</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Chan</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Modlin</surname>
            <given-names>IM</given-names>
          </name>
          <article-title>Neuroendocrine tumor epidemiology: contrasting Norway and North America</article-title>
          <source>Cancer</source>
          <year>2008</year>
          <volume>113</volume>
          <issue>10</issue>
          <fpage>2655</fpage>
          <lpage>2664</lpage>
          <pub-id pub-id-type="doi">10.1002/cncr.23883</pub-id>
          <pub-id pub-id-type="pmid">18853416</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Eltawil</surname>
            <given-names>KM</given-names>
          </name>
          <name>
            <surname>Gustafsson</surname>
            <given-names>BI</given-names>
          </name>
          <name>
            <surname>Kidd</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Modlin</surname>
            <given-names>IM</given-names>
          </name>
          <article-title>Neuroendocrine tumors of the gallbladder: an evaluation and reassessment of management strategy</article-title>
          <source>J Clin Gastroenterol</source>
          <year>2010</year>
          <volume>44</volume>
          <issue>10</issue>
          <fpage>687</fpage>
          <lpage>695</lpage>
          <pub-id pub-id-type="pmid">20375728</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hemminki</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>X</given-names>
          </name>
          <article-title>Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden</article-title>
          <source>Cancer</source>
          <year>2001</year>
          <volume>92</volume>
          <issue>8</issue>
          <fpage>2204</fpage>
          <lpage>2210</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(20011015)92:8&lt;2204::AID-CNCR1564&gt;3.0.CO;2-R</pub-id>
          <pub-id pub-id-type="pmid">11596039</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Modlin</surname>
            <given-names>IM</given-names>
          </name>
          <name>
            <surname>Oberg</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Chung</surname>
            <given-names>DC</given-names>
          </name>
          <name>
            <surname>Jensen</surname>
            <given-names>RT</given-names>
          </name>
          <name>
            <surname>de Herder</surname>
            <given-names>WW</given-names>
          </name>
          <name>
            <surname>Thakker</surname>
            <given-names>RV</given-names>
          </name>
          <name>
            <surname>Caplin</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Delle</surname>
            <given-names>FG</given-names>
          </name>
          <name>
            <surname>Kaltsas</surname>
            <given-names>GA</given-names>
          </name>
          <article-title>Krenning EP and others</article-title>
          <source>Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol</source>
          <year>2008</year>
          <volume>9</volume>
          <issue>1</issue>
          <fpage>61</fpage>
          <lpage>72</lpage>
          <pub-id pub-id-type="doi">10.1016/S1470-2045(07)70410-2</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Modlin</surname>
            <given-names>IM</given-names>
          </name>
          <name>
            <surname>Shapiro</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Kidd</surname>
            <given-names>M</given-names>
          </name>
          <article-title>An analysis of rare carcinoid tumors: clarifying these clinical conundrums</article-title>
          <source>World J Surg</source>
          <year>2005</year>
          <volume>29</volume>
          <issue>1</issue>
          <fpage>92</fpage>
          <lpage>101</lpage>
          <pub-id pub-id-type="doi">10.1007/s00268-004-7443-z</pub-id>
          <pub-id pub-id-type="pmid">15599742</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>El</surname>
            <given-names>DD</given-names>
          </name>
          <name>
            <surname>Khalifa</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Ismiil</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Wong</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ghorab</surname>
            <given-names>Z</given-names>
          </name>
          <article-title>Primary colorectal small cell carcinoma: a clinicopathological and immunohistochemical study of 10 cases</article-title>
          <source>Diagn Pathol</source>
          <year>2007</year>
          <volume>2</volume>
          <fpage>35</fpage>
          <pub-id pub-id-type="doi">10.1186/1746-1596-2-35</pub-id>
          <pub-id pub-id-type="pmid">17803816</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Deehan</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Heys</surname>
            <given-names>SD</given-names>
          </name>
          <name>
            <surname>Kernohan</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Eremin</surname>
            <given-names>O</given-names>
          </name>
          <article-title>Carcinoid tumour of the gall bladder: two case reports and a review of published works</article-title>
          <source>Gut</source>
          <year>1993</year>
          <volume>34</volume>
          <issue>9</issue>
          <fpage>1274</fpage>
          <lpage>1276</lpage>
          <pub-id pub-id-type="doi">10.1136/gut.34.9.1274</pub-id>
          <pub-id pub-id-type="pmid">8406168</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Modlin</surname>
            <given-names>IM</given-names>
          </name>
          <name>
            <surname>Lye</surname>
            <given-names>KD</given-names>
          </name>
          <name>
            <surname>Kidd</surname>
            <given-names>M</given-names>
          </name>
          <article-title>A 5-decade analysis of 13,715 carcinoid tumors</article-title>
          <source>Cancer</source>
          <year>2003</year>
          <volume>97</volume>
          <issue>4</issue>
          <fpage>934</fpage>
          <lpage>959</lpage>
          <pub-id pub-id-type="doi">10.1002/cncr.11105</pub-id>
          <pub-id pub-id-type="pmid">12569593</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Maitra</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Tascilar</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hruban</surname>
            <given-names>RH</given-names>
          </name>
          <name>
            <surname>Offerhaus</surname>
            <given-names>GJ</given-names>
          </name>
          <name>
            <surname>Albores-Saavedra</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Small cell carcinoma of the gallbladder: a clinicopathologic, immunohistochemical, and molecular pathology study of 12 cases</article-title>
          <source>Am J Surg Pathol</source>
          <year>2001</year>
          <volume>25</volume>
          <issue>5</issue>
          <fpage>595</fpage>
          <lpage>601</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-200105000-00005</pub-id>
          <pub-id pub-id-type="pmid">11342770</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Roa</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>de Aretxabala</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Araya</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Roa</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Preneoplastic lesions in gallbladder cancer</article-title>
          <source>J Surg Oncol</source>
          <year>2006</year>
          <volume>93</volume>
          <issue>8</issue>
          <fpage>615</fpage>
          <lpage>23</lpage>
          <pub-id pub-id-type="doi">10.1002/jso.20527</pub-id>
          <pub-id pub-id-type="pmid">16724345</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Paniz</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Slova</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Fan</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Attiyeh</surname>
            <given-names>FF</given-names>
          </name>
          <name>
            <surname>Afthinos</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Reidy</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Pang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Theise</surname>
            <given-names>ND</given-names>
          </name>
          <article-title>Mixed adenoneuroendocrine carcinoma (MANEC) of the gallbladder: a possible stem cell tumor?</article-title>
          <source>Pathol Int</source>
          <year>2011</year>
          <volume>61</volume>
          <issue>10</issue>
          <fpage>608</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1440-1827.2011.02709.x</pub-id>
          <pub-id pub-id-type="pmid">21951672</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Sakamoto</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Mutoh</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Ido</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Satoh</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Hayakawa</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Sugano</surname>
            <given-names>K</given-names>
          </name>
          <article-title>A close relationship between intestinal metaplasia and Cdx2 expression in human gallbladders with cholelithiasis</article-title>
          <source>Hum Pathol</source>
          <year>2007</year>
          <volume>38</volume>
          <issue>1</issue>
          <fpage>66</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="doi">10.1016/j.humpath.2006.06.010</pub-id>
          <pub-id pub-id-type="pmid">16996572</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Soga</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Primary endocrinomas (carcinoids and variant neoplasms) of the gallbladder. A statistical evaluation of 138 reported cases</article-title>
          <source>J Exp Clin Cancer Res</source>
          <year>2003</year>
          <volume>22</volume>
          <issue>1</issue>
          <fpage>5</fpage>
          <lpage>15</lpage>
          <pub-id pub-id-type="pmid">12725316</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Shimizu</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Tajiri</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Akimaru</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Arima</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yoshida</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Yokomuro</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Mamada</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Taniai</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Mizuguchi</surname>
            <given-names>Y</given-names>
          </name>
          <article-title>Kawahigashi Y and others</article-title>
          <source>Combined neuroendocrine cell carcinoma and adenocarcinoma of the gallbladder: report of a case. J Nihon Med Sch</source>
          <year>2006</year>
          <volume>73</volume>
          <issue>2</issue>
          <fpage>101</fpage>
          <lpage>5</lpage>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Noda</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Miwa</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kitagawa</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Carcinoid tumors of the gallbladder with adenocarcinomatous differentiation: a morphologic and immunohistochemical study</article-title>
          <source>Am J Gastroenterol</source>
          <year>1989</year>
          <volume>84</volume>
          <issue>8</issue>
          <fpage>953</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">2756987</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Sakaki</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hirokawa</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sano</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Horiguchi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Wakatsuki</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ogata</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Gallbladder Adenocarcinoma with Florid Neuroendocrine Cell Nests and Extensive Paneth Cell Metaplasia</article-title>
          <source>Endocr Pathol</source>
          <year>2000</year>
          <volume>11</volume>
          <issue>4</issue>
          <fpage>365</fpage>
          <lpage>371</lpage>
          <pub-id pub-id-type="doi">10.1385/EP:11:4:365</pub-id>
          <pub-id pub-id-type="pmid">12114761</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ahn</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Byun</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Ko</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Park</surname>
            <given-names>SH</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>MG</given-names>
          </name>
          <article-title>Case report: neuroendocrine carcinoma of the gallbladder causing hyperinsulinaemic hypoglycaemia</article-title>
          <source>Clin Radiol</source>
          <year>2007</year>
          <volume>62</volume>
          <issue>4</issue>
          <fpage>391</fpage>
          <lpage>394</lpage>
          <pub-id pub-id-type="doi">10.1016/j.crad.2006.11.016</pub-id>
          <pub-id pub-id-type="pmid">17331836</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Beltran</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Barria</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Heterotopic pancreas in the gallbladder: the importance of an uncommon condition</article-title>
          <source>Pancreas</source>
          <year>2007</year>
          <volume>34</volume>
          <issue>4</issue>
          <fpage>488</fpage>
          <lpage>491</lpage>
          <pub-id pub-id-type="doi">10.1097/MPA.0b013e31803816fc</pub-id>
          <pub-id pub-id-type="pmid">17446856</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Reid</surname>
            <given-names>KM</given-names>
          </name>
          <name>
            <surname>Ramos-De</surname>
            <given-names>LMA</given-names>
          </name>
          <name>
            <surname>Donohue</surname>
            <given-names>JH</given-names>
          </name>
          <article-title>Diagnosis and surgical management of gallbladder cancer: a review</article-title>
          <source>J Gastrointest Surg</source>
          <year>2007</year>
          <volume>11</volume>
          <issue>5</issue>
          <fpage>671</fpage>
          <lpage>681</lpage>
          <pub-id pub-id-type="doi">10.1007/s11605-006-0075-x</pub-id>
          <pub-id pub-id-type="pmid">17468929</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Giang</surname>
            <given-names>TH</given-names>
          </name>
          <name>
            <surname>Ngoc</surname>
            <given-names>TT</given-names>
          </name>
          <name>
            <surname>Hassell</surname>
            <given-names>LA</given-names>
          </name>
          <article-title>Carcinoma involving the gallbladder: a retrospective review of 23 cases - pitfalls in diagnosis of gallbladder carcinoma</article-title>
          <source>Diagn Pathol</source>
          <year>2012</year>
          <volume>7</volume>
          <fpage>10</fpage>
          <pub-id pub-id-type="doi">10.1186/1746-1596-7-10</pub-id>
          <pub-id pub-id-type="pmid">22284391</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Rindi</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Kloppel</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Alhman</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Caplin</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Couvelard</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>de Herder</surname>
            <given-names>WW</given-names>
          </name>
          <name>
            <surname>Erikssson</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Falchetti</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Falconi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Komminoth</surname>
            <given-names>P</given-names>
          </name>
          <article-title>TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system</article-title>
          <source>Virchows Arch</source>
          <year>2006</year>
          <volume>449</volume>
          <issue>4</issue>
          <fpage>395</fpage>
          <lpage>401</lpage>
          <pub-id pub-id-type="doi">10.1007/s00428-006-0250-1</pub-id>
          <pub-id pub-id-type="pmid">16967267</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Modlin</surname>
            <given-names>IM</given-names>
          </name>
          <name>
            <surname>Kidd</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Latich</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Zikusoka</surname>
            <given-names>MN</given-names>
          </name>
          <name>
            <surname>Shapiro</surname>
            <given-names>MD</given-names>
          </name>
          <article-title>Current status of gastrointestinal carcinoids</article-title>
          <source>Gastroenterology</source>
          <year>2005</year>
          <volume>128</volume>
          <issue>6</issue>
          <fpage>1717</fpage>
          <lpage>1751</lpage>
          <pub-id pub-id-type="doi">10.1053/j.gastro.2005.03.038</pub-id>
          <pub-id pub-id-type="pmid">15887161</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Duffy</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Capanu</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Abou-Alfa</surname>
            <given-names>GK</given-names>
          </name>
          <name>
            <surname>Huitzil</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Jarnagin</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Fong</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>D'Angelica</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Dematteo</surname>
            <given-names>RP</given-names>
          </name>
          <name>
            <surname>Blumgart</surname>
            <given-names>LH</given-names>
          </name>
          <name>
            <surname>O'Reilly</surname>
            <given-names>EM</given-names>
          </name>
          <article-title>Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC)</article-title>
          <source>J Surg Oncol</source>
          <year>2008</year>
          <volume>98</volume>
          <issue>7</issue>
          <fpage>485</fpage>
          <lpage>489</lpage>
          <pub-id pub-id-type="doi">10.1002/jso.21141</pub-id>
          <pub-id pub-id-type="pmid">18802958</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cucinotta</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Lorenzini</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Lazzara</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Melita</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Melita</surname>
            <given-names>P</given-names>
          </name>
          <article-title>[Intraperitoneal neoplastic dissemination of incidental gallbladder carcinoma after laparoscopic surgery]</article-title>
          <source>Tumori</source>
          <year>2003</year>
          <volume>89</volume>
          <issue>4</issue>
          <fpage>34</fpage>
          <lpage>39</lpage>
          <pub-id pub-id-type="pmid">12903540</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Z'Graggen</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Birrer</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Maurer</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Wehrli</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Klaiber</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Baer</surname>
            <given-names>HU</given-names>
          </name>
          <article-title>Incidence of port site recurrence after laparoscopic cholecystectomy for preoperatively unsuspected gallbladder carcinoma</article-title>
          <source>Surgery</source>
          <year>1998</year>
          <volume>124</volume>
          <issue>5</issue>
          <fpage>831</fpage>
          <lpage>838</lpage>
          <pub-id pub-id-type="doi">10.1016/S0039-6060(98)70005-4</pub-id>
          <pub-id pub-id-type="pmid">9823395</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Nau</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Dillhoff</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Forster</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hazey</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Melvin</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Two cases of small cell carcinoma of the gallbladder</article-title>
          <source>Case Report Med</source>
          <year>2010</year>
          <volume>453624</volume>
          <fpage>4</fpage>
        </mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Iype</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Mirza</surname>
            <given-names>TA</given-names>
          </name>
          <name>
            <surname>Propper</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Bhattacharya</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Feakins</surname>
            <given-names>RM</given-names>
          </name>
          <name>
            <surname>Kocher</surname>
            <given-names>HM</given-names>
          </name>
          <article-title>Neuroendocrine tumours of the gallbladder: three cases and a review of the literature</article-title>
          <source>Postgrad Med J</source>
          <year>2009</year>
          <volume>85</volume>
          <issue>1002</issue>
          <fpage>213</fpage>
          <lpage>218</lpage>
          <pub-id pub-id-type="doi">10.1136/pgmj.2008.070649</pub-id>
          <pub-id pub-id-type="pmid">19417172</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Grande</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Diez</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Pachon</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Carrato</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Advances in the therapy of gastroenteropancreatic-neuroendocrine tumours (GEP-NETs)</article-title>
          <source>Clin Transl Oncol</source>
          <year>2010</year>
          <volume>12</volume>
          <issue>7</issue>
          <fpage>481</fpage>
          <lpage>492</lpage>
          <pub-id pub-id-type="doi">10.1007/s12094-010-0541-5</pub-id>
          <pub-id pub-id-type="pmid">20615825</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Soga</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Carcinoids and their variant endocrinomas. An analysis of 11842 reported cases</article-title>
          <source>J Exp Clin Cancer Res</source>
          <year>2003</year>
          <volume>22</volume>
          <issue>4</issue>
          <fpage>517</fpage>
          <lpage>530</lpage>
          <pub-id pub-id-type="pmid">15053292</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Clark</surname>
            <given-names>OH</given-names>
          </name>
          <name>
            <surname>Benson</surname>
            <given-names>AR</given-names>
          </name>
          <name>
            <surname>Berlin</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Choti</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Doherty</surname>
            <given-names>GM</given-names>
          </name>
          <name>
            <surname>Engstrom</surname>
            <given-names>PF</given-names>
          </name>
          <name>
            <surname>Gibbs</surname>
            <given-names>JF</given-names>
          </name>
          <name>
            <surname>Heslin</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Kessinger</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Kulke MH and others</article-title>
          <source>NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors. J Natl Compr Canc Netw</source>
          <year>2009</year>
          <volume>7</volume>
          <issue>7</issue>
          <fpage>712</fpage>
          <lpage>747</lpage>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
